QDEL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
QuidelOrtho Corp (QDEL) is not a strong buy at this moment for a beginner investor with a long-term focus. While there are some positive catalysts such as insider buying and a potential for a 4.27% gain in the next month, the technical indicators, financial performance, and mixed analyst ratings do not strongly support a buy decision. The lack of strong proprietary trading signals further supports a hold recommendation.
The MACD is slightly positive, indicating mild bullish momentum, but the RSI is neutral at 31.058, showing no clear signal. The moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading near its key support level of 15.396, suggesting limited upside potential in the short term.
Insiders are buying significantly, with a 2578.44% increase in buying activity over the last month. Additionally, the stock has an 80% chance of gaining 4.27% in the next month based on historical patterns.
The company reported a YoY revenue decline of -3.74% in Q3 2025, and its net income and EPS, while improving, are still negative. Analyst ratings are mixed, with no clear consensus, and the stock is currently underperforming in pre-market trading.
In Q3 2025, revenue dropped by -3.74% YoY to $699.9M. However, net income improved significantly to -$733M (up 3583.42% YoY), and EPS increased to -10.78 (up 3493.33% YoY). Gross margin slightly declined to 41.13% (-0.44% YoY).
Analyst ratings are mixed. Citi and UBS maintain Neutral ratings with price targets of $30, while JPMorgan has an Underweight rating with a $25 price target. UBS noted mixed guidance for 2026, focusing on free cash flow.
